For some self-pay cancer patients in the United States, cancer care can become financially out of reach. A high treatment estimate is not simply a price; it can determine whether treatment remains possible.

When a patient is medically able to proceed with treatment, a high U.S. estimate does not have to end the search. The next question is whether another clinically appropriate treatment pathway is available in time and at a manageable total cost.

A review with Korean hospitals can help clarify that question. Korea has internationally recognized cancer hospitals. In Newsweek and Statista’s 2026 oncology ranking, Samsung Medical Center, Asan Medical Center, and Seoul National University Hospital were ranked among the world’s top 10 cancer hospitals.

U.S. treatment prices reflect a fragmented insurance system, complex billing processes, and high commercial hospital prices. Korea has a more standardized hospital pricing environment, although international self-pay patients are billed separately. The comparison should include clinical suitability, treatment availability, timing, hospital charges, travel, accommodation, caregiver needs, and follow-up care.

APIS helps patients and families prepare the medical records required for review and coordinates communication with Korean hospitals.

Sources: Newsweek / Statista, World’s Best Specialized Hospitals 2026 – Oncology